Latest filing published 26 Jun 2026 for Eton Pharmaceuticals, Inc., €7.9M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Gruber James R.: trading record in brief
Gruber James R. is a declared insider of Eton Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 2 June 2026 to 26 June 2026, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 26 June 2026 came the latest disclosure, a transaction for €7.9M in Eton Pharmaceuticals, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gruber James R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 251,818 shares@ US$35.70040.93% mcap92.5% of flowCommonSEC144:0001974078-26-000256
- 25,000 shares@ US$35.01CommonSEC144:0001974078-26-000255
- 25,000 shares@ US$33.235CommonSEC144:0001974078-26-000254
3 of 3 declarations
